VVX-002

N/A

Report date: 2025/01/26 16:27:50

Base Information

Drug NameVVX-002
Drug Alias Namepeptide-carrier fusion technology vaccine (Viravaxx)VVX-002
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccinesBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesViravaxx Ag
China Registration ClassN/A

Develop Information

Active CompaniesViravaxx Ag
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A